Riskpilot← Back to searchSign inGet full accessGesynta Pharma AB
ABActiveOrg 5591036628Wallingatan 24 2trResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20175-9 employees
Revenue 2024
SEK 0
EBITDA margin
—
+24% vs 2023
Equity ratio
20.7%
Financial strength
Net profit 2024
SEK -15,2M
+24% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -15,5M | +24% |
| Net profit | SEK -15,2M | +24% |
| Total assets | SEK 28,2M | +87% |
| Equity | SEK 5,8M | -52% |
| Employees | — | — |
Legal name
Gesynta Pharma AB
Org number
5591036628
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7 mars 2017
Share capital
SEK 371 204
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av Ekberg, Elin Kristina Franklin, Roger James Jendi, Jonas Scarinci, Daniele Timothy Simula, Pekka i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva forskning, utveckling och kommersialisering av läkemedel och därmed förenlig verksamhet.
Address
Wallingatan 24 2tr
Email
patric.stenberg@gesynta.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 891 | 702 | 0 | 187 | 0 | 0 | 47 | 0 |
| Staff expenses | — | — | — | — | — | — | — | −6 007 |
| EBITDA | −32 | −12 357 | −35 123 | −48 570 | −79 835 | −80 096 | −20 354 | −15 487 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −53 | −53 | −53 | −34 |
| EBIT | −32 | −12 357 | −35 123 | −48 570 | −79 888 | −80 149 | −20 407 | −15 521 |
| Net financials | — | 13 | 94 | 110 | 198 | 296 | 480 | 296 |
| Profit before tax | −32 | −12 344 | −35 029 | −48 459 | −79 691 | −79 852 | −19 927 | −15 225 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — |
| Net profit | −32 | −12 344 | −35 029 | −48 459 | −79 691 | −79 852 | −19 927 | −15 225 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 569 | 16 478 | 39 924 | 92 323 | 114 228 | 34 229 | 15 066 | 28 170 |
| Equity | 318 | 11 222 | 37 095 | 85 315 | 101 644 | 22 117 | 12 190 | 5 840 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 251 | 5 256 | 2 829 | 7 007 | 12 584 | 12 112 | 2 875 | 22 330 |
| Total debt | 251 | 5 256 | 2 829 | 7 007 | 12 584 | 12 112 | 2 875 | 22 330 |
EBITDA margin
-1548705100.0%
This company
15.8%
Market median
-9801931113% vs market
20172024
Equity ratio
20.7%
This company
38.2%
Market median
-46% vs market
20172024
Return on equity
-260.7%
This company
18.4%
Market median
-1517% vs market
20172024
Net profit margin
-1522456900.0%
This company
8.1%
Market median
-18795764298% vs market
20172024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
3.82×
This company
0.62×
Market median
-516% vs market
20172024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-03-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BM Chief Auditor | Chief Auditor | 2020 | — | — |
PS Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
BC Audit | Audit | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gesynta Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Magnus Lagerberg | Chief Auditor | 0 companies |
| Patric Stenberg | Chief Executive Officer | 0 companies |
| Bo Christer Eriksson | Audit | 0 companies |
| Per-Johan Göte Jakobsson | Board of Directors | 0 companies |
| Markus Dietrich | Board of Directors | 0 companies |
| Daniele Timothy Scarinci | Board of Directors | 0 companies |
| Jonas Jendi | Board of Directors | 0 companies |
| Elin Kristina Ekberg | Board of Directors | 0 companies |
| Thomas Emanuel Bergh | Board of Directors | 0 companies |
| Gunnar Olof Olsson | Board of Directors | 0 companies |
| Bita Sehat | Board of Directors | 0 companies |
| Pekka Simula | Board of Directors | 0 companies |
| Jonas Karl Olof Brambeck | Board of Directors | 0 companies |
| David Colpman | Board of Directors | 0 companies |
| Charlotte Elisabet Edenius | Board of Directors | 0 companies |
| Lars Urban Paulsson | Chairman | 0 companies |
| Roger James Franklin | Chairman | 0 companies |
| Cristina Ileana Csimma | Board of Directors | 0 companies |
| Christina Ileana Csimma | Board of Directors | 0 companies |
| Nikolaj Arrild Sörensen | Board of Directors | 0 companies |
| Maarten De Chateau | Board of Directors | 0 companies |